Tania F.
- Country
- Spain
- Department
- Oncology
Research Overview
- Pumitamig plus Combination Therapy Versus Nivolumab plus Combination Therapy in Previously Untreated Advanced or Metastatic Gastric, GEJ, or Esophageal Adenocarcinoma
- Phase 2 Randomized Open‑Label Study of Denikitug Monotherapy vs Combination Therapy in HER2‑negative Unresectable Metastatic Gastric/GEJ/Esophageal Adenocarcinoma
- Switch Maintenance with Paclitaxel, Ramucirumab and Tislelizumab vs Continued Chemotherapy plus Tislelizumab in HER2‑negative, PD‑L1‑positive Gastroesophageal Adenocarcinoma
Data & Insights
Has run more than one trial at 82 of 268 partner sites.
Specializations
Hormone‑Driven Breast Oncology
Focus on Estrogen Receptor Positive HER2 Negative disease states across early, locally advanced and metastatic settings.
- ER+/HER2‑negative Advanced Breast Cancer
- HR‑positive/HER2‑negative Early Breast Cancer
- HER2‑low Breast Cancer with Brain Metastases
Research integrates endocrine therapy, CDK4/6 inhibition and emerging targeted agents.
Hematologic Malignancies
Investigations span acute and chronic myeloid disorders and lymphoid cancers.
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Diffuse Large B‑Cell Lymphoma
Emphasis on molecular sub‑typing and novel immunotherapeutic strategies.
Mutation‑Driven Solid Tumors
Targeted programs address cancers harboring actionable driver alterations.
- KRAS G12C Mutated Non‑Small Cell Lung Cancer
- EGFR‑mutant NSCLC
- BRAF V600E Colorectal Cancer
Therapeutic approaches include selective inhibitors and combination regimens.
Cardiovascular and Hepatic Failure Syndromes
Clinical programs evaluate acute and chronic heart disease as well as liver decompensation.
- Acute Heart Failure post‑Myocardial Infarction
- Atherosclerotic Cardiovascular Disease
- Acute‑on‑Chronic Liver Failure
Studies incorporate biomarker‑guided risk stratification and organ‑protective therapies.
Autoimmune and Inflammatory Disorders
Research addresses systemic autoimmune conditions with high unmet need.
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Immune Thrombocytopenia
Efforts focus on cytokine modulation and targeted immunomodulators.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.